Jamshid Gadoev

Learn More
Multidrug-resistant tuberculosis (MDR-TB; resistance to at least rifampicin and isoniazid) is a global public health concern. In 2010–2011, Uzbekistan, in central Asia, conducted its first countrywide survey to determine the prevalence of MDR-TB among TB patients. The proportion of MDR-TB among new and previously treated TB patients throughout the country(More)
D J Ulmasova1, G Uzakova2, M N Tillyashayhov3, L Turaev4, W van Gemert5, H Hoffmann6, M Zignol5, K Kremer7, T Gombogaram8, J Gadoev8, P du Cros9, N Muslimova4, A Jalolov2, A Dadu7, P de Colombani7, O Telnov10, A Slizkiy10, B Kholikulov1, M Dara7, D Falzon (falzond@who.int)5 1. Republican DOTS Centre, Tashkent, Uzbekistan 2. Programme Implementation Unit,(More)
BACKGROUND TB is one of the main health priorities in Uzbekistan and relatively high rates of unfavorable treatment outcomes have recently been reported. This requires closer analysis to explain the reasons and recommend interventions to improve the situation. Thus, by using countrywide data this study sought to determine trends in unfavorable outcomes(More)
SETTINGS Tuberculosis (TB) health facilities in the Gomel Region, Republic of Belarus-settings with a high burden of multidrug-resistant TB (MDR-TB) and human immunodeficiency virus (HIV) infection. OBJECTIVE To determine treatment outcomes among MDR-TB patients diagnosed in 2009-2010 and factors associated with unsuccessful outcomes (death, failure and(More)
SETTING Latvia, an Eastern European country with a high burden of tuberculosis (TB). OBJECTIVE To describe treatment outcomes among new drug-susceptible TB patients and assess the association of treatment outcomes with selected social determinants and risk factors. DESIGN A retrospective cohort study of patients aged ⩾15 years registered during(More)
BACKGROUND In Uzbekistan, despite stable and relatively high tuberculosis treatment success rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent tuberculosis is when a patient who was treated for pulmonary tuberculosis and cured, later develops the disease again. This requires closer analysis to identify possible(More)
  • 1